Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk – Combined Results from Two Screening Trials
Steven J. Skates(Massachusetts General Hospital), Karen H. Lu(The University of Texas MD Anderson Cancer Center), Wendy R. Brewster(University of North Carolina at Chapel Hill), David M. O’Malley(The Ohio State University), Patrick M. Sluss(Harvard University), Gustavo C. Rodriguez(NorthShore University HealthSystem), Charles W. Drescher(Gynecologic Oncology Group), Lori M. Minasian(National Cancer Institute), Andrew Berchuck(General Marble (Greece)), Kelly‐Anne Phillips(The University of Melbourne), John F. Boggess(University of Kentucky), William J. Welch(University of British Columbia), Steven A. Elg(Iowa Lutheran Hospital), Joan L. Walker(Cornell University), Dianne M. Finkelstein(Harvard University), Carol J. Fabian(Washington Hospital), Susan Nayfield(University of Florida), Susan M. Domchek(University City Science Center), Katie Wakeley(South Shore Hospital), Claudine Isaacs(Georgetown University), Nora Horick(Massachusetts General Hospital), Saundra S. Buys(University of Utah), John O. Schorge(St. Jude Children's Research Hospital), Carol H. Kasten(United States Food and Drug Administration), Mark H. Greene(Cancer Institute (WIA)), Deborah K. Armstrong(Johns Hopkins University), Susan A. Davidson(Denver Health Medical Center), Edward E. Partridge(University of Alabama at Birmingham), Thomas F. Rutherford(University of Wisconsin–Madison), Mary B. Daly(Fox Chase Cancer Center), Marion Piedmonte(Roswell Park Comprehensive Cancer Center), Ira Horowitz(Gynecologic Oncology Group), David S. Alberts(University of Arizona), Mark E. Sherman(Mayo Clinic in Florida), Robert P. Edwards(Magee-Womens Research Institute), Powel Brown(The University of Texas MD Anderson Cancer Center)
Cited by 139
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
|JNCI Journal of the National Cancer Institute|1995|3.4k
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k